Lana Klionsky
Amgen (United States)(US)
Publications by Year
Research Areas
Ion Channels and Receptors, Pain Mechanisms and Treatments, Neurobiology and Insect Physiology Research, Herbal Medicine Research Studies, Phytochemicals and Antioxidant Activities
Most-Cited Works
- → AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties(2005)386 cited
- → Molecular Determinants of Vanilloid Sensitivity in TRPV1(2004)355 cited
- → The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation(2007)308 cited
- → Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade(2007)172 cited
- → Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1 H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats(2008)160 cited
- → Species-Specific Pharmacology of Trichloro(Sulfanyl)ethyl Benzamides as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists(2007)109 cited
- → Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl Cinnamides(2004)102 cited
- → Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles(2006)83 cited
- → Proton Activation Does Not Alter Antagonist Interaction with the Capsaicin-Binding Pocket of TRPV1(2005)82 cited
- → Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists(2012)55 cited